Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

471.16
Delayed Data
As of May 01
 +13.70 / +2.99%
Today’s Change
269.50
Today|||52-Week Range
495.50
+14.85%
Year-to-Date

Today’s Trading

Previous close457.46
Today’s open463.02
Day’s range462.45 - 474.97
Volume710,998
Average volume (3 months)856,619
Market cap$47.7B
Dividend yield--
Data as of 3:59pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+5.12%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio153.5
Price/Sales14.64
Price/Book18.98

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+5.02+4.93%
QQuintiles Transnatio...+1.42+2.16%
ISISIsis Pharmaceuticals...+1.52+2.68%
ICLRICON PLC+1.37+2.13%
Data as of 4:14pm ET, 05/01/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$2.70
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers